Treatment of deep vein thrombosis with low molecular weight heparins at home

Treatment of patients with proximal vein thrombosis with low molecular weight heparins is effective and safe. So it allows "hospital at home" care. Among low molecular weight heparins tinzaparin is given once daily, making the compliance easier. The twenty patients with deep vein thrombosi...

Full description

Saved in:
Bibliographic Details
Published inAnales de medicina interna (Madrid, Spain : 1984) Vol. 20; no. 3; pp. 134 - 136
Main Authors Suárez Alvarez, C G, García Cañete, J, Herrero Mendoza, M D, Bellver Alvarez, T M, Arboiro Pinel, R
Format Journal Article
LanguageSpanish
Published Spain 01.03.2003
Subjects
Adult
Aged
Aged, 80 and over
Ambulatory Care - methods
Female
Fibrinolytic Agents - therapeutic use
Heparin, Low-Molecular-Weight - therapeutic use
Home Care Services, Hospital-Based
Humans
Male
Middle Aged
Risk Factors
Treatment Outcome
Venous Thrombosis - drug therapy
Online AccessGet full text

Cover

More Information
Summary:Treatment of patients with proximal vein thrombosis with low molecular weight heparins is effective and safe. So it allows "hospital at home" care. Among low molecular weight heparins tinzaparin is given once daily, making the compliance easier. The twenty patients with deep vein thrombosis who were assisted in the "hospital at home" unit of the Clínica Nuestra Señora de la Concepción in Madrid from December 1999 to December 2000. The mean of age was 71 + 15. The most frequent risk factors were surgery in past three months (19%), known tumour (15%) and previous venous thrombosis (15%). Eighteen patients were treated with tinzaparin. No patients showed adverse effects nor complications. Low molecular weight heparins, specially tinzaparin, are a safe and effective treatment for deep vein thrombosis in our unit.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0212-7199